miR-661 downregulates both Mdm2 and Mdm4 to activate p53

Area of Science:

• Molecular Biology
• Cancer Research
• Genetics

Background:

• The p53 pathway is critical for tumor suppression and tightly regulated by Mdm2 and Mdm4 proteins.
• MicroRNAs (miRNAs) are key regulators of gene expression, impacting mRNA levels and translation.
• Maintaining cellular homeostasis relies on the precise balance of p53, Mdm2, and Mdm4.

Purpose of the Study:

• To investigate the role of primate-specific miR-661 in regulating Mdm2 and Mdm4.
• To determine the impact of miR-661 on p53 activity and cancer cell behavior.
• To explore the cell type-dependent and p53 status-dependent functions of miR-661 in cancer.

Main Methods:

• Investigated miR-661 targeting of Mdm2 and Mdm4 mRNA in living cells.
• Assessed the effect of miR-661 on p53 activity, cell cycle progression, and cell migration.
• Correlated miR-661 expression levels with clinical outcomes in breast cancer patients.

Main Results:

• miR-661 directly targets both Mdm2 and Mdm4 mRNA in a cell type-dependent manner, with a stronger effect on Mdm2.
• miR-661 binding sites on Mdm2 and Mdm4 mRNAs are located within Alu elements, suggesting a primate-specific regulatory mechanism.
• In p53-proficient cells, miR-661 augments p53 activity and inhibits cell cycle progression.
• Low miR-661 expression correlates with poor outcomes in wild-type p53 breast cancers.
• In p53-mutated tumors, miR-661 locus amplification is observed, and miR-661 promotes cell migration.

Conclusions:

• miR-661 acts as a regulator of the p53 pathway by targeting Mdm2 and Mdm4.
• miR-661 exhibits dual roles in cancer, potentially suppressing or promoting aggressiveness based on p53 mutational status.
• The findings highlight a primate-specific regulatory mechanism involving miRNAs and repetitive elements in cancer.